Copyright © Inderes 2011 - present. All rights reserved.

Spago Nanomedical

0.12 SEK

+3.51 %

Less than 1K followers

SPAGO

First North Stockholm

Biotechnology & Pharmaceuticals

Health Care

+3.51 %
+1.29 %
+15.69 %
+0.03 %
-40.73 %
-22.17 %
-74.28 %
-98.04 %
-98.54 %

Spago Nanomedical is active in biotechnology. The company develops nanomedicine for the diagnosis and treatment of life-threatening diseases. The company's main activities are focused on developing a cancer-selective contrast agent for magnetic resonance imaging (MRI), as well as a product for radionuclide treatment of cancer. Both of these projects are based on proprietary nanomaterials. The largest operations are in the Nordic market, with the headquarters located in Lund.

Read more
Market cap
78.07M SEK
Turnover
46.07K SEK
Revenue
1.91M
EBIT %
-1,764.92 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
4.2
2026

Annual report '25

6.5
2026

Interim report Q1'26

10.6
2026

General meeting '26

ShowingAll content types

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.